Teflaro 600 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FG1WS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,808
Award facts
- Contract value 100% obligated
- $11,807.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,807.65 delivery order to AmerisourceBergen Drug Corp for the supply of Teflaro 600 mg vials, an antibiotic medication used primarily in military and federal healthcare systems. This non-set-aside, competitively awarded delivery order carries a firm fixed price and has an ultimate completion date of December 5, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical federal pharmaceutical vendor with an extensive portfolio of medical product deliveries to the DLA Medical Supply Chain and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's SPE2DX contract represents a prime vendor arrangement designed to provide flexible access to specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of reliable pharmaceutical distribution to federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FG1WS?
SPE2DR26FG1WS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FG1WS worth?
The government has obligated $11,808 on SPE2DR26FG1WS.
Is contract SPE2DR26FG1WS an order under another contract?
Yes. SPE2DR26FG1WS is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1WS competed?
The extent of competition for SPE2DR26FG1WS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award